Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Health Effects of Soccer Training in Men With Prostate Cancer Receiving Androgen Deprivation Therapy

16. april 2014 oppdatert av: Jacob Uth, University of Copenhagen

A Randomized Controlled Clinical Trial on the Effects of Recreational Soccer Training in Men With Prostate Cancer Receiving Androgen Deprivation Therapy: The FC Prostate Study

Androgen Deprivation Therapy (ADT) is standard treatment for locally advanced or advanced Prostate Cancer (PC).

The musculoskeletal toxicity associated with ADT is well established, leading to a decrease in muscle mass, increased fat percentage, weight gain, sexual dysfunction and increased risk of depression, fatigue, diabetes, cardiovascular disease and reduced quality of life.

Numerous studies have shown an association between physical activity, physical capacity and quality of life in cancer patients and recent epidemiological research suggest that regular, moderate-intensity physical activity may have a positive effect on survival in men with prostate cancer.

Within exercise physiology there is new evidence pointing to recreational soccer as a unique form of intermittent exercise that effectively stimulates aerobic and anaerobic energy delivery systems, leading to beneficial musculoskeletal, metabolic and cardiovascular adaptations of importance for health.

It is our overall hypothesis that 12 weeks of recreational soccer training 2-3 times per week will improve the health profile of PC patients receiving ADT treatment.

Studieoversikt

Status

Fullført

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Faktiske)

57

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

  • Danmark
      • Copenhagen, Danmark, 2100
        • University of Copenhagen, Centre of Integrated Rehabilitation of Cancer Patients

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 75 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Mann

Beskrivelse

Inclusion Criteria:

- Patients with locally advanced or advanced prostate cancer being treated with androgen deprivation therapy (S-testosterone < 1.7) for at least 6 months at the time of inclusion

Exclusion Criteria:

  • WHO performance level above 1,symptomatic cardiovascular disorders, osteoporosis (T-score below -2.5)

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Ingen inngripen: Kontrollgruppe
Vanlig omsorg
Aktiv komparator: Soccer Training
12 weeks of soccer training. (2 times per week for the first 8 weeks and 3 times per week in the last 4 weeks. Training will consist of 15 minutes warm-up and 2 x 15 minutes matches for the first 4 weeks and of 15 minutes warm-up and 3 x 15 minutes matches for the last 8 weeks). After 12 weeks assessments participants in the intervention group will continue bi-weekly supervised training for additional 20 weeks at the end of which tests will be repeated.
Atferdsmessig: Soccer training

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Baseline to post intervention (12 weeks) and follow-up (32 weeks) change in Body Composition.
Tidsramme: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Changes in body composition assessed by Dual-energy X-ray absorptiometry(DXA)scan
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Bone Mineral Density
Tidsramme: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Cardiorespiratory fitness (Vo2 peak)
Tidsramme: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Change in maximal oxygen consumption (Vo2 peak) assessed directly during an incremental test on a cycle ergometer from baseline to post-intervention (12 weeks) and follow-up (32 weeks).
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Patient reported outcomes
Tidsramme: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Changes in Psychological distress (Hospital Anxiety and Depression Scale, HADS), Quality of Life (EORTC QLQ C-30), general well-being (SF-36), disease specific symptoms and side-effects (EORTC PR-25)from baseline to post-intervention (12 weeks) and follow-up (32 weeks)
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Heart function
Tidsramme: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Changes in Heart function measured by Echocardiography from baseline to post-intervention (12 weeks) and follow-up (32 weeks)
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Glucose tolerance
Tidsramme: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Oral Glucose Tolerance Test
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Postural Balance
Tidsramme: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Assessed standing on a force platform with feet in bilateral, unilateral and tandem position. Additionally assessed with a modified Flamingo balance test.
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Physical function
Tidsramme: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Physical function will be assessed with sit to stand test (30s), stair climbing test and Counter Movement Jump (jump height)
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Hip to waist ratio
Tidsramme: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Hip and waist circumference will be measured and the hip to waist ratio will be calculated
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Muscle Strength
Tidsramme: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Muscle strength will be assessed with the 1Repetition Maximum test for knee extensors
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Blood markers
Tidsramme: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Markers of inflammation and bone metabolism will be obtained after overnight fasting
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

University of Copenhagen

Samarbeidspartnere

Novo Nordisk A/S
Danish Cancer Society
TrygFonden, Denmark
Beckett Foundation

Etterforskere

  • Hovedetterforsker: Mikael Rørth, Professor, University of Copenhagen

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. mars 2012

Primær fullføring (Faktiske)

1. desember 2013

Studiet fullført (Faktiske)

1. desember 2013

Datoer for studieregistrering

Først innsendt

17. oktober 2012

Først innsendt som oppfylte QC-kriteriene

18. oktober 2012

Først lagt ut (Anslag)

22. oktober 2012

Oppdateringer av studieposter

Sist oppdatering lagt ut (Anslag)

21. april 2014

Siste oppdatering sendt inn som oppfylte QC-kriteriene

16. april 2014

Sist bekreftet

1. april 2014

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • CIRE-04

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på Prostatiske neoplasmer

Kliniske studier på Soccer training

Søk i lignende forsøk

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

CROs by country

CROs in Albania

Forhold

Sjeldne sykdommer

Legemiddelintervensjoner

Kosttilskudd

Sponsor / samarbeidspartnere

Steder

Abonnere